ICD-10 Coding for BRCA2 Positive(Z14.8, Z15.01, Z15.01B)
Learn about the ICD-10 coding and documentation requirements for BRCA2 positive status, including genetic testing and risk assessment.
Complete code families applicable to BRCA2 Positive
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Z15.01 | Genetic susceptibility to malignant neoplasm of breast | Use when a patient has a confirmed BRCA2 mutation that increases breast cancer risk. |
|
| Z15.02 | Genetic susceptibility to malignant neoplasm of ovary | Use when a patient has a confirmed BRCA2 mutation that increases ovarian cancer risk. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBRCA2 Positive
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting BRCA2 Positive.
Omitting family history in documentation
Impact
Clinical: Incomplete risk assessment, Regulatory: Non-compliance with documentation standards, Financial: Potential claim denials
Mitigation
Always document family history when relevant, Use templates to ensure completeness
Using Z14.8 instead of Z15.01 for BRCA2 mutations
Impact
Reimbursement: Incorrect coding may lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records and data reporting.
Mitigation
Use Z15.01 specifically for BRCA2 mutations related to breast cancer risk.
Genetic Testing Documentation
Impact
Incomplete documentation of genetic testing results can lead to audit findings.
Mitigation
Ensure all genetic test results and risk assessments are fully documented.